Abstract Aims Mesenchymal stromal cells (MSCs) gradually become attractive candidates
for cardiac inflammation modulation, yet understanding of the mechanism remains elusive …

Background Myocardial ischemia-reperfusion injury is a type of myocardial ischemia that
has a significant impact on patients' health. We aimed to explore the protective effect of …

Exosomes are served as substitutes for stem cell therapy, playing important roles in
mediating heart repair during myocardial infarction injury. Evidence have indicated that …

Mesenchymal stem cells (MSCs) have been shown to be efficacy to attenuating
cardiovascular inflammation; however, there are many limitations to stem cell treatment …

Background/Aims: Bone marrow mesenchymal stem cells (MSCs) widely applied for treating
myocardial infarction face survival challenges in the inflammatory and ischemia …

Abstract Background Mesenchymal stromal cells (MSCs) activated with IFN-γ elicit stronger
physical effects. Exosomes (Exos) secreted from MSCs show protective effects against …

Our previous study demonstrated the beneficial effects of exosomes secreted by cardiac
mesenchymal stem cells (C-MSC-Exo) in protecting acute ischemic myocardium from …

Aims The inflammation modulation effects of mesenchymal stromal cell-derived exosomes
(MSC-EXO) are well established. We aimed to explore the mechanism behind the …

Background/Aims: Reperfusion after an ischaemic insult might cause infarct extension.
Mesenchymal stem cell (MSC)-derived exosomes could attenuate myocardial remodelling in …

Accumulating evidence has shown that mesenchymal stem cell (MSC)‐derived exosomes
(exo) mediate cardiac repair following myocardial infarction (MI). Macrophage migration …